Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for ...

Organ-on-a-chip systems offer a more accurate, ethical, and scalable alternative to animal testing in drug discovery and ...

Esophageal adenocarcinoma (EAC), one of two major forms of esophageal cancer, is the sixth most deadly cancer worldwide for which no effective targeted therapy exists.

Scientists at National Taiwan University have developed a new microfluidic system that can detect subtle chemical ...

Scientists developed a new microfluidic system that can detect subtle chemical fingerprints from bacteria - helping identify even antibiotic-resistant strains. This technology could help physicians ...

Cedars-Sinai owns a minority stock interest in Emulate, the company that produces the study's microfluidic Organ-Chips. An officer of Cedars-Sinai also serves on Emulate's Board of Directors. C.N.S ...

Market SynopsisThe Global In-vitro Lung Model Market is valued at USD 0.71 billion in 2024 and is projected to reach a value ...

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best Canadian stocks with huge upside potential. Earlier in May, AbCellera Biologics announced that the US Court of Appeals for the Federal ...

AbCellera Biologics Inc. (NASDAQ:ABCL) discovers and develops antibody-based medicines for indications with unmet medical ...

Lab-on-a-chip, or microfluidic, technologies are tiny devices usually made from a transparent, rubbery material that can be ...

AbCellera Biologics Inc. (NASDAQ:ABCL) is one of the best Canadian stocks with huge upside potential. Earlier in May, AbCellera Biologics announced that the US Court of Appeals for the Federal Circuit ...